ARPA-H DECIDE Exploration Topic
The DECIDE (Decentralized Engineering of Cells Informed by Dynamic Evidence) Exploration Topic aims to advance new quality assurance technologies and accelerate the collection of evidence necessary to establish reimbursement pathways for rare disease therapies. If successful, ARPA-H believes the work in this arena would increase patients’ access to life-changing therapies from Academic Medical Centers (AMCs).
ARPA-H will make the technologies and methods it develops through DECIDE-ET accessible to industry stakeholders. It will also work with federal agencies on relevant regulatory and reimbursement issues, that may also present formidable challenges to downstream development and adoption.
Program Manager: Darshak Sanghavi, M.D.
Learn more at:
https://arpa-h.gov/news-and-events/ar...